Practical Electrocardiology and Clinical Treatment, Volume. 34, Issue 3, 353(2025)

Risk factors for poor outcomes in patients with type 2 diabetes mellitus complicating coronary heart disease

OU Changyuan and LI Qusheng
Author Affiliations
  • Department of Cardiology, Changning People's Hospital, Hengyang Hunan 421500, China
  • show less
    References(11)

    [1] [1] TAS F, OZTURK A, ERTURK K. Comorbidity in small cell lung cancer: prognostic impacts of hypertension/coronary artery disease, diabetes mellitus, and chronic obstructive pulmonary disease[J]. Cancer Invest, 2024, 42(1): 21-33.

    [2] [2] DING Y, SHAN D, HAN T, et al. Incremental prognostic value of perivascular fat attenuation index in patients with diabetes with coronary artery disease[J]. Radiol Cardiothorac Imaging, 2025, 7(2): e240242. DOI: 10.1148/ryct.240242.

    [3] [3] KARAGIANNIDIS E, MOYSIDIS DV, PAPAZOGLOU AS, et al. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease [J]. Cardiovasc Diabetol, 2022, 21(1): 70. DOI: 10.1186/s12933-022-01494-9.

    [4] [4] ICHIKAWA K, MIYOSHI T, OSAWA K, et al. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study [J]. Cardiovasc Diabetol, 2021, 20(1): 8. DOI: 10.1186/s12933-020-01192-4.

    [7] [7] CHEN S, GUAN S, YAN Z, et al. Prognostic value of red blood cell distribution width-to-albumin ratio in ICU patients with coronary heart disease and diabetes mellitus[J]. Front Endocrinol (Lausanne), 2024, 15: 1359345. DOI: 10.3389/fendo.2024.1359345.

    [8] [8] CHITSAZAN M, CHITSAZAN M. The role of free fatty acids as a prognostic biomarker in coronary artery disease patients with type 2 diabetes [J]. Eur J Prev Cardiol, 2023, 30(8): 728-729.

    [9] [9] HE J, SONG C, WANG H, et al. Diabetes mellitus with mild or moderate kidney dysfunction is associated with poor prognosis in patients with coronary artery disease: a large-scale cohort study [J]. Diabetes Res Clin Pract, 2023, 200: 110693. DOI: 10.1016/j.diabres. 2023.110693.

    [10] [10] CHITTARAGI GH, AMBALI AP, HONNUTAGI R, et al. Interleukin-6 and uric acid among type 2 diabetes mellitus patients with coronary artery disease [J]. Bioinformation, 2023, 19(12): 1134-1138.

    [11] [11] TIAN R, LIU H, FENG S, et al. Gut microbiota dysbiosis in stable coronary artery disease combined type 2 diabetes mellitus influence cardiovascular prognosis [J]. Nutr Metab Cardiovasc Dis, 2021, 31(5): 1454-1466.

    [12] [12] WEI W, ZHANG L, LI G, et al. Prevalence and prognostic significance of malnutrition in diabetic patients with coronary artery disease: a cohort study [J]. Nutr Metab (Lond), 2021, 18(1): 102. DOI: 10.1186/s12986-021-00626-4.

    [13] [13] LIN Y, ZHOU F, WANG X, et al. Effect of the index of cardiac electrophysiological balance on major adverse cardiovascular events in patients with diabetes complicated with coronary heart disease [J]. PeerJ, 2023, 11: e15969. DOI: 10.7717/peerj.15969.

    Tools

    Get Citation

    Copy Citation Text

    OU Changyuan, LI Qusheng. Risk factors for poor outcomes in patients with type 2 diabetes mellitus complicating coronary heart disease[J]. Practical Electrocardiology and Clinical Treatment, 2025, 34(3): 353

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Feb. 20, 2025

    Accepted: Aug. 22, 2025

    Published Online: Aug. 22, 2025

    The Author Email:

    DOI:10.13308/j.issn.2097-5716.2025.03.008

    Topics